News Pfizer will have to cut price of AML drug Mylotarg after NIC... NICE blocks access to 65% of patients on cost grounds
News FDA approves Pfizer's epoetin biosimilar Retacrit Epoetin alfa biosimilars available in EU for more than a decade
News Pfizer eyes AI-powered drug discovery and development softwa... Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI).
News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety Conference London 2018
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
